Actively Recruiting
The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction
Led by University Hospital, Angers · Updated on 2025-07-23
250
Participants Needed
9
Research Sites
235 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The prevalence of Caesarean sections continues to increase around the world. In France, the proportion of Caesarean sections has doubled from 11% in 1981 to 20,2% in 2016, bringing with it an increase in the risk of obstetrical complications. Uterine defects, or Isthomcele, first defined by Morris in 1995 as a scarring abnormality with a dehiscence of the hysterotomy following a caesarean section. This purely iatrogenic pathology can cause inter-menstrual bleeding or pelvic pain. Several definitions of isthmosceles exist in scientific literature with variations according to the nature of the reference examination chosen and the measurements made. However, for the majority of authors, isthmoceles are characterized by a residual myometrial thickness of less than 3 millimetres in the sagittal plane. The prevalence of isthmoceles amoung patients with a unicicatricial uterus is about 61%. Currently, the main diagnostic technique for isthmoceles are 2D or 3D ultrasound and hysterosonography. Small, non-controlled studies have found that surgical treatment of the isthmocele is effective in reducing metrorrhagia. In these studies, the authors noted that patients with metrorrhagia were also more frequently affected by secondary infertility. A small number of non-comparative studies with a low level of evidence have looked into the efficacy of surgical treatment of isthmoceles on related symptoms: metrorraghia, pelvic pain and/or secondary infertility. Their results show an idiopathic secondary infertility rate in the presence of isthmoceles prior to surgical treatment of approximately 66%. Significantly higher pregnancy rates after treatment suggest that the surgical management of isthmoceles is worthwhile. However, these data suffer from not negligible selection bias. The initial findings concerning fertility after surgical repair seem promising and some teams propose systematic surgical management of the isthmocele before a technique of assisted reproduction (ART) although without any evidence in literature. Isthmocele surgery can result in uterine perforations, adhesions and intrauterine synechia known to be detrimental to future fertility. The efficacy of surgical management of surgey must therefore be demonstrated prior to any attempts at treatment. This will require large prospective studies based on a consensual definition of isthmocele. The diagnosis using Hysterosonography is currently considered as the "gold standard" examination. The main hypothesis of our study is that a significant isthmocele, defined by a residual myometrial thickness of less than 3mm, measured in the sagittal plane by hysterosonography, could alter the results of ART.
CONDITIONS
Official Title
The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a history of at least one cesarean section (single or multi-scarred uterus)
- Age between 18 and 43 years old
- Secondary infertility requiring ART techniques (FIV or FIV ICSI)
- Undergoing hysterosonography as part of the pre-ART assessment to detect isthmocele presence
- French speaking patients
- Patients affiliated with or beneficiaries of a social security scheme
You will not qualify if you...
- Refusal to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
UH Angers
Angers, France, 49933
Actively Recruiting
2
University Hospital of Brest
Brest, France
Actively Recruiting
3
Hospital Center Sud Francilien
Corbeil-Essonnes, France
Actively Recruiting
4
Creteil University Hospital
Créteil, France
Actively Recruiting
5
University Hospital of Nimes
Nîmes, France
Actively Recruiting
6
Tenon Hospital Paris
Paris, France
Actively Recruiting
7
La Sagesse Clinic
Rennes, France
Actively Recruiting
8
University Hospital of Rennes
Rennes, France
Actively Recruiting
9
University Hospital of Saint Etienne
Saint-Etienne, France
Actively Recruiting
Research Team
G
Guillaume LEGENDRE, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here